Herein, it was observed that FOXN3 over-expression repressed AKT/MDM2/p53 signaling transduction in glioma cells, whereas FOXN3 ablation facilitated the activation of AKT/MDM2/p53 signaling axis. This evidence concerns the gene AKT1 and central nervous system cancer.